 |
|
|
Jun '07 |
Sep '07 |
Dec '07 |
Mar '08 |
Jun '08 |
|
| Sales Turnover |
508.81 |
541.28 |
733.91 |
581.64 |
670.81 |
| Other Income |
238.79 |
232.81 |
226.42 |
248.31 |
261.34 |
| Total Income |
747.60 |
774.09 |
960.33 |
829.95 |
932.15 |
| Total Expenses |
499.68 |
562.32 |
581.48 |
560.18 |
630.04 |
| Operating Profit |
9.13 |
-21.04 |
152.43 |
21.46 |
40.77 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
247.92 |
211.77 |
378.85 |
269.77 |
302.11 |
| Interest |
-- |
-- |
-- |
-- |
-- |
| PBDT |
247.92 |
211.77 |
378.85 |
269.77 |
302.11 |
| Depreciation |
13.54 |
13.69 |
14.05 |
14.83 |
14.28 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
234.38 |
198.08 |
364.80 |
254.94 |
287.83 |
| Tax |
8.99 |
3.25 |
18.87 |
7.05 |
7.05 |
| Net Profit |
225.39 |
194.83 |
345.93 |
247.89 |
280.78 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
11.44 |
9.78 |
17.17 |
11.97 |
13.56 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
98.55 |
99.59 |
100.72 |
103.56 |
103.56 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
5.00 |
5.00 |
5.00 |
5.00 |
5.00 |
|
 |
|
|
|
| BSE: 524715 |
NSE: SUNPHARMA |
Reuters: SUN.BO SUN.NS |
|
 |
| Source : Asian CERC |
 |